OBSOLETE: Genetic primary hypomagnesemia with normocalciuria

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:306522
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic primary hypomagnesemia with normocalciuria is a rare inherited condition where the body cannot properly maintain normal levels of magnesium in the blood. The term 'OBSOLETE' in the disease name means that this classification has been retired or merged into other, more specific diagnostic categories as medical understanding has improved. The condition falls under a broader group of inherited magnesium-wasting disorders. In this condition, the kidneys lose too much magnesium into the urine, leading to chronically low magnesium levels in the blood (hypomagnesemia), while calcium levels in the urine remain normal (normocalciuria). This distinction from conditions that also cause abnormal calcium in the urine is important for diagnosis. Low magnesium can affect many body systems, particularly muscles and nerves. Patients may experience muscle cramps, tremors, weakness, fatigue, numbness or tingling, and in severe cases, seizures or abnormal heart rhythms. Treatment typically involves magnesium supplementation, either by mouth or intravenously in acute situations. Because this Orphanet entry is now obsolete, patients previously classified under this code may now be reclassified under more specific genetic diagnoses such as familial hypomagnesemia with secondary hypocalcemia, isolated renal magnesium wasting, or other related channelopathies. Patients should work with a geneticist to determine their precise genetic diagnosis for the most accurate management plan.

Key symptoms:

Muscle cramps and spasmsTremors or shakingMuscle weaknessFatigue and tirednessNumbness or tingling in hands and feetSeizuresIrregular heartbeat or heart palpitationsIrritability or mood changesPoor appetiteNausea or vomitingDifficulty concentrating

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Genetic primary hypomagnesemia with normocalciuria.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Genetic primary hypomagnesemia with normocalciuria at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Genetic primary hypomagnesemia with normocalciuria community →

No specialists are currently listed for OBSOLETE: Genetic primary hypomagnesemia with normocalciuria.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Genetic primary hypomagnesemia with normocalciuria.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Genetic primary hypomagnesemia with normocalciuriaForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Genetic primary hypomagnesemia with normocalciuria.

Start the conversation →

Latest news about OBSOLETE: Genetic primary hypomagnesemia with normocalciuria

No recent news articles for OBSOLETE: Genetic primary hypomagnesemia with normocalciuria.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact genetic cause of my magnesium problem, and has the diagnosis been updated from the obsolete classification?,What magnesium supplement type and dose is best for me, and how can I manage side effects like diarrhea?,How often should my blood and urine electrolyte levels be checked?,What warning signs should prompt me to seek emergency care?,Are there any medications I should avoid because they could lower my magnesium further?,Should my family members be tested for this condition?,Are there any clinical trials or new treatments being studied for my specific genetic type?

Common questions about OBSOLETE: Genetic primary hypomagnesemia with normocalciuria

What is OBSOLETE: Genetic primary hypomagnesemia with normocalciuria?

Genetic primary hypomagnesemia with normocalciuria is a rare inherited condition where the body cannot properly maintain normal levels of magnesium in the blood. The term 'OBSOLETE' in the disease name means that this classification has been retired or merged into other, more specific diagnostic categories as medical understanding has improved. The condition falls under a broader group of inherited magnesium-wasting disorders. In this condition, the kidneys lose too much magnesium into the urine, leading to chronically low magnesium levels in the blood (hypomagnesemia), while calcium levels i